CloudCath Connect™ PD

About CloudCath

CloudCath is a private, commercial-stage company focused on transforming home-based peritoneal dialysis care through its remote patient monitoring platform. Its core technology objectively quantifies dialysis fluid turbidity, identifying signs of peritonitis an average of 3.1 days earlier than patient-reported symptoms, as validated in a 2024 clinical study. This early detection has demonstrated significant clinical outcomes, including a 45% reduction in hospitalization and a 56% reduction in catheter loss, potentially improving patient retention on PD therapy. The company targets a critical need in the growing home dialysis market by providing data-driven tools for clinicians and patients.

Therapeutic Areas